Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2002 1
2003 1
2004 1
2005 1
2006 1
2007 2
2008 3
2009 16
2010 12
2011 10
2012 18
2013 10
2014 13
2015 14
2016 18
2017 12
2018 20
2019 25
2020 14
2021 27
2022 18
2023 25
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ. Duffield AS, et al. Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24. Virchows Arch. 2023. PMID: 36422706 Free PMC article. Review.
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL) includes both revisions to subtypes previously outlined in the 2016 WHO classification and sever …
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute …
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. Arber DA, et al. Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11. Blood. 2016. PMID: 27069254 Free article. Review.
Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnostic c …
Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute …
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P, Mecucci C, La Starza R. Bardelli V, et al. Genes (Basel). 2021 Jul 23;12(8):1118. doi: 10.3390/genes12081118. Genes (Basel). 2021. PMID: 34440292 Free PMC article. Review.
T-cell acute lymphoblastic leukemias (T-ALL) are immature lymphoid tumors localizing in the bone marrow, mediastinum, central nervous system, and lymphoid organs. They account for 10-15% of pediatric and about 25% of adult acute lymphoblastic …
T-cell acute lymphoblastic leukemias (T-ALL) are immature lymphoid tumors localizing in the bone marrow, mediastinum, c …
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH, Wan CL, Dai HP, Xue SL. Huang YH, et al. Ann Hematol. 2023 Aug;102(8):2001-2013. doi: 10.1007/s00277-023-05286-3. Epub 2023 May 25. Ann Hematol. 2023. PMID: 37227492 Review.
T cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is an aggressive malignancy of progenitor T cells. ...These findings led to pre-clinical studies and clinical trials of molecular targeted therapy in T-ALL/LBL. Furthermore, immunot …
T cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is an aggressive malignancy of progenitor T c …
T-cell acute lymphoblastic leukemia.
Raetz EA, Teachey DT. Raetz EA, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):580-588. doi: 10.1182/asheducation-2016.1.580. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913532 Free PMC article. Review.
T-cell acute lymphoblastic leukemia (T-ALL) is biologically distinct from its B lymphoblastic (B-ALL) counterpart and shows different kinetic patterns of disease response. ...Similar to B-ALL, the key prognostic determinant in T-ALL is minimal r …
T-cell acute lymphoblastic leukemia (T-ALL) is biologically distinct from its B lymphoblastic (B-ALL) cou …
T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
Vadillo E, Dorantes-Acosta E, Pelayo R, Schnoor M. Vadillo E, et al. Blood Rev. 2018 Jan;32(1):36-51. doi: 10.1016/j.blre.2017.08.006. Epub 2017 Aug 15. Blood Rev. 2018. PMID: 28830639 Review.
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult ALL cases, respectively. ...Furthermore, we compare the extravasation potential of T-ALL cells with that of other hematologic malignancies such as …
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult ALL cases, res …
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia.
Lato MW, Przysucha A, Grosman S, Zawitkowska J, Lejman M. Lato MW, et al. Int J Mol Sci. 2021 Apr 26;22(9):4502. doi: 10.3390/ijms22094502. Int J Mol Sci. 2021. PMID: 33925883 Free PMC article. Review.
Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer that accounts for 10-15% of T-cell acute lymphoblastic leukemia (T-ALL) cases. ...These include therapies that inhibit Notch1 activation (bortezomib), JAK …
Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer that accounts for 10-15% of T-cell …
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
Patel J, Gao X, Wang H. Patel J, et al. Int J Mol Sci. 2023 Apr 13;24(8):7201. doi: 10.3390/ijms24087201. Int J Mol Sci. 2023. PMID: 37108359 Free PMC article. Review.
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly improved the survival rate for patients, but mortality rates remain high owing to relapsed disease, therapy resistance, or treatment-related toxicities/infection. .. …
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly improved the survival rat …
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K, Sheikh T, Aggarwal N. Davis K, et al. Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9. Semin Diagn Pathol. 2023. PMID: 37120350 Review.
Tremendous strides have been made in the molecular and cytogenetic classification of acute lymphoblastic leukemia based on gene expression profiling data, leading to an expansion of entities in the recent International Consensus Classification (ICC) of myeloi …
Tremendous strides have been made in the molecular and cytogenetic classification of acute lymphoblastic leukemia based …
How I Diagnose Acute Leukemia of Ambiguous Lineage.
Weinberg OK, Arber DA. Weinberg OK, et al. Am J Clin Pathol. 2022 Jul 1;158(1):27-34. doi: 10.1093/ajcp/aqac070. Am J Clin Pathol. 2022. PMID: 35775438 Review.
OBJECTIVES: Classification of acute leukemia involves assigning lineage by resemblance to normal progenitor cells. ...The different treatment regimens for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) m …
OBJECTIVES: Classification of acute leukemia involves assigning lineage by resemblance to normal progenitor cells. ...T …
233 results